Medicine Information

Bextra and Vioxx Withdrawal Spurs Price Increase Among Rivals


The market for painkillers is huge. People don't like pain and inflammation, and last year Americans spent nearly $4 billion on just two of them - Vioxx and Bextra. Those two drugs, part of a family of non-steroidal anti-inflammatory drugs known as COX-2 inhibitors, were withdrawn from the market recently amid concerns that they can cause heart attacks and strokes. The loss of these two drugs to the marketplace is huge, as they were the two largest sellers in a fairly narrow field. COX-2 inhibitors differ from traditional non-steroidal anti-inflammatory drugs in that they inhibit production of the COX-2 enzyme that causes inflammation but do not interfere with COX-1, the enzyme that protects the stomach lining. Patients who use these drugs are thought to suffer less from internal discomfort and bleeding than those who took traditional anti-inflammatories, such as naproxen and ibuprofen.

With the withdrawal of these two blockbusters, patients with chronic pain, such as arthritis sufferers, are now going back to older painkillers, such as Mobic, Motrin, and Relafen. Since the more popular Vioxx and Bextra are no longer available, these older drugs are enjoying a resurgence in popularity, and sales are up across the board. So, it seems, are their prices. A recent study by a popular consumer publication shows that prices of some three dozen anti-inflammatory medications have gone up since Vioxx was withdrawn from the market in September 2004. The increases average about ten percent. Why have the prices of these older, established medications all gone up at once?

The answer, simply, is that the pharmaceutical companies have raised the prices because they can. The market for drugs is wildly competitive, and manufacturers are constantly seeking any advantage they can find in the marketplace. The sudden withdrawal of two of the most popular and profitable medications has provided a rare opportunity for manufacturers to increase both sales and prices at the same time, as the drug makers know that patients must switch to another medication. It's good for their stockholders, but bad for those who suffer from pain.

Will the high prices last? Probably not. Pricing of highly competitive medications tends to be volatile. The prices may stay up in the short term, but other medications may be introduced soon, or Bextra or Vioxx may be returned to the market. The introduction of other drugs will restore more competition to the market, and prices may drop once again. The market for painkilling drugs is a bit of a crazy one, and patients should simply exhibit some, well, patience.

Copyright 2005 by Retro Marketing.

Charles Essmeier is the owner of Retro Marketing, a firm devoted to informational Websites, including Bextra-Info.net, a site devoted to the withdrawn drug Bextra and StructuredSettlementHelp.com, a site devoted to structured settlements.


MORE RESOURCES:
This RSS feed URL is deprecated, please update. New URLs can be found in the footers at https://news.google.com/news


Medscape

Marrying or Medicine: Does a White Coat Make Dating Harder?
Medscape
After 4 years of medical school and 2 years of residency, my impression is that love and medicine can be a tricky thing. As a physician, I have dedicated my life to my training. That being said, part of being a human is enjoying the companionship of ...



Symposium supports theme of Women in Medicine Month
Healio
The American Medical Association deems September Women in Medicine Month, when the AMA Women Physicians Section honors physicians who support advancement of women in medical careers. At the Women in Ophthalmology 2018 Summer ...



WBOY.com

WVU Medicine announces plans to offer heart transplants | WVU ...
WVU Medicine (press release)
WVU Medicine announced today (Sept. 19) its plans to start West Virginia's first heart transplant program at the WVU Heart and Vascular Institute.
WVU Medicine to offer heart transplantsWest Virginia MetroNews
WVU Medicine announce first heart transplant programWBOY.com
WVU Medicine to offer heart transplants - Dominion PostThe Dominion Post
WV News
all 63 news articles »


The BMJ

Seven days in medicine: 12-18 September 2018
The BMJ
Several leading journals including the Lancet and the New England Journal of Medicine are working to correct the record. “It is my hope that this situation will inspire a doubling down on transparency in our field,” he wrote in his resignation letter.

and more »


OKCThunder.com

Oklahoma City Thunder, OU Medicine Announce Innovative New ...
OKCThunder.com
OKLAHOMA CITY, Wednesday, September 19, 2018 – The Oklahoma City Thunder and OU Medicine today announced a unique and innovative 10-year ...

and more »


KRVS

Medicine Ball Caravan: September 20, 2018
KRVS
Thursday's MEDICINE BALL CARAVAN on KRVS (11am-noon Central Standard on 88.7FM locally or krvs.org) runs the newest from The Record Company, The Grip Weeds and Zuider Zee. Also: The Chris Leblanc Band cover The Beatles live along with ...



Science Magazine

Evidence-based medicine group expels internal critic
Science Magazine
A crisis has erupted within Cochrane, an international network of scientists that promotes evidence-based medicine. On the eve of its annual conference, held earlier this week in Edinburgh, Cochrane's 13-member Governing Board voted to expel Peter ...



Morehouse School of Medicine Awarded $200000 to Train Minority Physicians for Recruiting Minorities in Clinical Trials
Newswise (press release)
Newswise — ATLANTA, September 20, 2018 — Morehouse School of Medicine (MSM) will launch a program specifically designed to increase the number of African-American, Latino and other minority patients in clinical trials, in an effort that could ...



Fortune

Health Is Politics on a Grand Scale
Fortune
This is what led Virchow to famously say, “Medicine is a social science and politics is nothing else but medicine on a large scale.” I would modify this slightly, and suggest that, in fact, politics is health on a large scale. It is, of course, true ...



UNC School of Medicine Study Shows Surprise Low-level Ozone Impact on Asthma Patients
Newswise (press release)
Newswise — CHAPEL HILL, NC – A new study led by UNC School of Medicine researchers indicates that ozone has a greater impact on asthma patients than previously thought. The study, published in The Journal of Allergy and Clinical Immunology, ...


Google News

home | site map | Dr. Thad Thomas
© 2006